Document Detail


Transmyocardial laser revascularization and angiogenesis: the potential for therapeutic benefit.
MedLine Citation:
PMID:  9930709     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Transmyocardial laser revascularization (TMR) has emerged as a promising therapy for ischemic heart disease in patients who are not candidates for more conventional therapies such as percutaneous transluminal coronary angioplasty or coronary artery bypass grafting. Although TMR provides symptomatic relief of angina and improved cardiovascular performance in a select patient population, the mechanism by which TMR works is still a controversial issue. Recently, it has been postulated that TMR evokes an angiogenic response and thereby improves local perfusion to ischemic myocardial territories. Herein we present a review of TMR and the molecular basis of angiogenesis.
Authors:
L Y Lee; T K Rosengart
Related Documents :
21605139 - Atrial fibrillation induced and converted by domestic supply electric shock.
16480939 - Local bioavailability and distribution of systemically (parenterally) administered iban...
14697459 - Incidence of recovery of contractile function following revascularization in patients w...
24324809 - Regulation of heat shock proteins 27 and 70, p-akt/p-enos and mapks by naringin dampens...
11511119 - Positron emission tomography using(18)f-fluoro-deoxyglucose and euglycaemic hyperinsuli...
251169 - Sexual activity in exercising patients after myocardial infarction and revascularization.
22767479 - Enteropathy associated t-cell lymphoma resulting in restrictive cardiomyopathy and mimi...
15276499 - Comparison of bilateral thoracic artery grafting with percutaneous coronary interventio...
17229299 - Validation and clinical application of time-frequency analysis of atrial fibrillation e...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in thoracic and cardiovascular surgery     Volume:  11     ISSN:  1043-0679     ISO Abbreviation:  Semin. Thorac. Cardiovasc. Surg.     Publication Date:  1999 Jan 
Date Detail:
Created Date:  1999-04-05     Completed Date:  1999-04-05     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8917640     Medline TA:  Semin Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  29-35     Citation Subset:  IM    
Affiliation:
Department of Cardiothoracic Surgery, New York Presbyterian Hospital-Weill Medical College of Cornell University, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Coronary Circulation
Endothelial Growth Factors / physiology
Fibroblast Growth Factors / physiology
Humans
Laser Therapy*
Lymphokines / physiology
Myocardial Ischemia / physiopathology,  surgery*
Myocardial Revascularization / methods*
Neovascularization, Physiologic / physiology
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
Chemical
Reg. No./Substance:
0/Endothelial Growth Factors; 0/Lymphokines; 0/Vascular Endothelial Growth Factor A; 0/Vascular Endothelial Growth Factors; 62031-54-3/Fibroblast Growth Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  An examination of potential mechanisms underlying transmyocardial laser revascularization induced in...
Next Document:  Combination TMR and gene therapy.